slides · global inventory
List
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 110,539
Current window 87,001-87,030
Pages 3,685
Rows per page 30
Component
87,001-87,030 of 110,539
26
The slide illustrates the mechanism of incorporating non-standard amino acids into antibodies for ADC development.Absci | Investor Presentation Deck | 37 slides · Absci
Pitch deck Investor relations 1 hit
28
Case study showing molecular weight validation of protein expression.Absci | Investor Presentation Deck | 37 slides · Absci
Pitch deck Investor relations 1 hit
29
The slide uses a four-column layout to categorize value propositions, each supported by a small icon or diagram.Absci | Investor Presentation Deck | 37 slides · Absci
Pitch deck Investor relations 1 hit
30
PoS stands for Probability of Success. The slide uses a comparative timeline framework to illustrate efficiency gains.Absci | Investor Presentation Deck | 37 slides · Absci
Pitch deck Investor relations 1 hit
03
Advantage Solutions | Investor Presentation Deck | 27 slidesAdvantage Solutions | Investor Presentation Deck | 27 slides · Advantage Solutions
Pitch deck Investor relations Beat · Problem1 hit
08
The slide uses a donut chart to illustrate market dominance.Advantage Solutions | Investor Presentation Deck | 27 slides · Advantage Solutions
Pitch deck Investor relations Beat · Market Size1 hit
27
This is the final page of a 6-part appendix section detailing financial adjustments.Advantage Solutions | Investor Presentation Deck | 27 slides · Advantage Solutions
Pitch deck Investor relations 1 hit
12
This is the fourth page of a four-part appendix disclosure regarding non-GAAP financial measures.Advantage Solutions | Results Presentation Deck | 13 slides · Advantage Solutions
Conference presentation Investor relations Beat · Appendix1 hit
09
Includes two testimonials from Key Opinion Leaders (KOLs) to emphasize the difficulty of treatment compliance.Aeglea BioTherapeutics | Investor Presentation Deck | 39 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Problem1 hit
10
The slide uses a pie chart for segmentation and a timeline/number line for diagnostic age, followed by key clinical metrics.Aeglea BioTherapeutics | Investor Presentation Deck | 39 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · AgitateLoop · Mece Breakdown1 hit
12
The chart shows a clear dose-response relationship between 1.0 mg/kg and 10.0 mg/kg doses, with statistical significance marked at early time points.Aeglea BioTherapeutics | Investor Presentation Deck | 39 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Solution1 hit
21
The slide uses a heatmap to visualize individual patient outcomes, a common technique in clinical trial reporting.Aeglea BioTherapeutics | Investor Presentation Deck | 39 slides · Aeglea BioTherapeutics
Pitch deck Investor relations 1 hit
22
Data presented as n (%).Aeglea BioTherapeutics | Investor Presentation Deck | 39 slides · Aeglea BioTherapeutics
Pitch deck Investor relations 1 hit
33
The slide uses a box plot to visualize longitudinal clinical trial data.Aeglea BioTherapeutics | Investor Presentation Deck | 39 slides · Aeglea BioTherapeutics
Pitch deck Investor relations 1 hit
04
Aeva | Results Presentation Deck | 14 slidesAeva | Results Presentation Deck | 14 slides · Aeva
Shareholder letter Investor relations 1 hit
08
Uses a 2x2-style quadrant map to illustrate competitive advantage.Aeva | Results Presentation Deck | 14 slides · Aeva
Shareholder letter Investor relations Loop · Aha Moment1 hit
09
Aeva | Results Presentation Deck | 14 slidesAeva | Results Presentation Deck | 14 slides · Aeva
Shareholder letter Investor relations Loop · Aha Moment1 hit
03
Hub-and-spoke diagram showing core business pillars.Alkermes | Investor Presentation Deck | 32 slides · Alkermes
Research note Investor relations Beat · Situation & ContextLoop · Golden Circle1 hit
05
Alkermes | Investor Presentation Deck | 32 slidesAlkermes | Investor Presentation Deck | 32 slides · Alkermes
Research note Investor relations Beat · Impact & Next StepsLoop · Golden Circle1 hit
07
Includes a boxed warning disclaimer at the bottom.Alkermes | Investor Presentation Deck | 32 slides · Alkermes
Research note Investor relations 1 hit
12
Alkermes | Investor Presentation Deck | 32 slidesAlkermes | Investor Presentation Deck | 32 slides · Alkermes
Research note Investor relations Beat · Evidence & Proof1 hit
13
Includes product branding, dosage options, and a bar chart showing revenue growth.Alkermes | Investor Presentation Deck | 32 slides · Alkermes
Research note Investor relations Beat · Evidence & Proof1 hit
14
Includes a callout regarding COVID-19 impact on 2020 sales.Alkermes | Investor Presentation Deck | 32 slides · Alkermes
Research note Investor relations Beat · Evidence & Proof1 hit
15
Alkermes | Investor Presentation Deck | 32 slidesAlkermes | Investor Presentation Deck | 32 slides · Alkermes
Research note Investor relations Beat · Evidence & Proof1 hit
17
Includes a medical illustration of brain pathways related to wakefulness and neurotransmitters.Alkermes | Investor Presentation Deck | 32 slides · Alkermes
Research note Investor relations Beat · Problem & ComplicationLoop · Cost Of Inaction1 hit
18
Includes a molecular visualization of the Orexin 2 receptor.Alkermes | Investor Presentation Deck | 32 slides · Alkermes
Research note Investor relations Beat · Evidence & ProofLoop · Cost Of Inaction1 hit
30
Includes disclaimer regarding non-GAAP reconciliation and specific business context (oncology spin-off, INVEGA royalties).Alkermes | Investor Presentation Deck | 32 slides · Alkermes
Research note Investor relations 1 hit
31
Alkermes | Investor Presentation Deck | 32 slidesAlkermes | Investor Presentation Deck | 32 slides · Alkermes
Research note Investor relations 1 hit
03
Allbirds | Investor Presentation Deck | 14 slidesAllbirds | Investor Presentation Deck | 14 slides · Allbirds
Pitch deck Investor relations 1 hit
04
Includes a financial table comparing Q4 2022 and Full Year 2022 results.Allbirds | Investor Presentation Deck | 14 slides · Allbirds
Pitch deck Investor relations Beat · ProblemLoop · Why Now1 hit